Exploration of the mutational landscape of cutaneous leiomyoma confirms FH as a driver gene and identifies targeting purine metabolism as potential therapeutic strategy

Published: 11 July 2024| Version 1 | DOI: 10.17632/78tbfhwkdf.1
Contributor:
David Adams

Description

Supplementary files to accompany the manuscript entitled "Exploration of the mutational landscape of cutaneous leiomyoma confirms FH as a driver gene and identifies targeting purine metabolism as potential therapeutic strategy"

Files

Institutions

Wellcome Sanger Institute

Categories

Cancer, DNA, Tumor, Skin, RNA, Citric Acid Cycle, Leiomyoma, Next Generation Sequencing

Funding

Medical Research Council

MR/V000292/1

Licence